These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5069316)

  • 61. Proceedings: The hepatotoxic effect of ethanol after pretreatment with carbon tetrachloride, allyl alcohol, or D-galactosamine.
    Strubelt O; Buettner F; Siegers CP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R102. PubMed ID: 1170506
    [No Abstract]   [Full Text] [Related]  

  • 62. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Histological and autoradiographic investigations of the galactosamine induced hepatitis of the rat].
    Lesch R; Reutter W; Deppler D; Decker K
    Verh Dtsch Ges Pathol; 1969; 53():350-5. PubMed ID: 4190745
    [No Abstract]   [Full Text] [Related]  

  • 64. Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency.
    Sabesin SM; Kuiken LB; Ragland JB
    Scand J Clin Lab Invest Suppl; 1978; 150():187-93. PubMed ID: 746347
    [No Abstract]   [Full Text] [Related]  

  • 65. [Pathogenic significance of endotoxemia in acute experimental liver failure].
    Fang YQ; Hou C
    Zhonghua Yi Xue Za Zhi; 1988 Mar; 68(3):147-9. PubMed ID: 3136893
    [No Abstract]   [Full Text] [Related]  

  • 66. Protective role of prednisolone upon galactosamine-induced hepatitis in rats.
    Grases PJ; Reutter W; Lesch R
    G E N; 1972; 27(2):197-204. PubMed ID: 4201408
    [No Abstract]   [Full Text] [Related]  

  • 67. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 68. [The antihepatotoxic effect of silymarin on liver damage in rats induced by carbon tetrachloride, d-galactosamine and allyl alcohol].
    Rauen HM; Schriewer H
    Arzneimittelforschung; 1971 Aug; 21(8):1194-201. PubMed ID: 5110018
    [No Abstract]   [Full Text] [Related]  

  • 69. Hepatic blood flow in rats with galactosamine hepatitis.
    Liehr H; Grün M; Thiel H; Krauss H; Rost R
    Acta Hepatogastroenterol (Stuttg); 1972; 19(4):259-63. PubMed ID: 4663715
    [No Abstract]   [Full Text] [Related]  

  • 70. Reversal of liver failure in rats by ultraviolet-irradiated hepatocyte transplantation.
    Kawai Y; Price JB; Hardy MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):989-91. PubMed ID: 3274437
    [No Abstract]   [Full Text] [Related]  

  • 71. In-vitro preparation of experimental models of hepatitis with D-galactosamine and their modification by liver-repairing factors.
    Takahashi N; Ishizuya T; Mori N
    Int J Tissue React; 1990; 12(5):263-8. PubMed ID: 2098368
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hepatotoxic effect of D-galactosamine and protective role of lipid emulsion.
    Ferencíková R; Cervinková Z; Drahota Z
    Physiol Res; 2003; 52(1):73-8. PubMed ID: 12625810
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cytoplasmic aggregates in D-galactosamine induced liver injury.
    Tompa A; Lapis K; Schaff Z; Mészáros K; Mandl J; Garzó T; Antoni F
    Acta Morphol Acad Sci Hung; 1977; 25(4):239-57. PubMed ID: 617770
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Studies into the mechanism of reversal of experimental acute hepatic failure by hepatocyte transplantation. 1.
    Makowka L; Rotstein LE; Falk RE; Falk JA; Zuk R; Langer B; Blendis LM; Phillips MJ
    Can J Surg; 1981 Jan; 24(1):39-44. PubMed ID: 7006772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The inhibition of rat liver nuclear ribonucleic acid synthesis by galactosamine and its reversal by uridine.
    Konishi Y; Shinozuka H; Farber JL
    Lab Invest; 1974 Jun; 30(6):751-6. PubMed ID: 4835601
    [No Abstract]   [Full Text] [Related]  

  • 76. [Function of lysosomal enzymes in galactosamine hepatitis].
    Heissmeyer H; Stein U
    Verh Dtsch Ges Inn Med; 1972; 78():1377-80. PubMed ID: 4665551
    [No Abstract]   [Full Text] [Related]  

  • 77. [Consumption coagulopathy with fibrin rich microcoagula in experimental rabbit hepatitis].
    Reuter C; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1973; 79():1340-2. PubMed ID: 4790175
    [No Abstract]   [Full Text] [Related]  

  • 78. Zinc content in liver of experimental fulminant hepatic failure rat.
    Kawanishi H; Nishiki M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Sep; 32(3):305-9. PubMed ID: 6358141
    [No Abstract]   [Full Text] [Related]  

  • 79. [Antihepatotoxic activity of arginine thiazolidinecarboxylate in hepatitis induced by galactosamine in the rat].
    Carminati R; Falchi M; Nebuloni R; Guadagni L; Lodi R
    Farmaco Prat; 1979 Apr; 34(4):163-7. PubMed ID: 456554
    [No Abstract]   [Full Text] [Related]  

  • 80. Ultrastructural studies on D-galactosamine-HCl-induced liver injury in mice.
    Lapis K; Schaff Z
    Morphol Igazsagugyi Orv Sz; 1973 Aug; 13(4):276-88. PubMed ID: 4724880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.